JPMORGAN CHASE & CO - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$3,362,186
-8.9%
64,782
+5.3%
0.00%
Q2 2023$3,690,178
+31.6%
61,544
+8.5%
0.00%
Q1 2023$2,805,000
+43213.8%
56,730
-50.0%
0.00%
-100.0%
Q4 2022$6,476
-98.9%
113,479
+829.5%
0.00%
Q3 2022$573,000
+17.2%
12,208
-6.9%
0.00%
Q2 2022$489,00013,1060.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders